CY1116436T1 - Αλατα και πολυμορφα μιας ενωσης τετρακυκλινης - Google Patents

Αλατα και πολυμορφα μιας ενωσης τετρακυκλινης

Info

Publication number
CY1116436T1
CY1116436T1 CY20151100497T CY151100497T CY1116436T1 CY 1116436 T1 CY1116436 T1 CY 1116436T1 CY 20151100497 T CY20151100497 T CY 20151100497T CY 151100497 T CY151100497 T CY 151100497T CY 1116436 T1 CY1116436 T1 CY 1116436T1
Authority
CY
Cyprus
Prior art keywords
salts
polymorphes
tetracycline
useful
tetracycline component
Prior art date
Application number
CY20151100497T
Other languages
English (en)
Inventor
Raymond Cvetovich
Tadeusz Warchol
Original Assignee
Paratek Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paratek Pharmaceuticals, Inc. filed Critical Paratek Pharmaceuticals, Inc.
Publication of CY1116436T1 publication Critical patent/CY1116436T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C07C231/24—Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C07C237/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
    • C07C309/30—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings of six-membered aromatic rings substituted by alkyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
    • C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Παρέχονται κρυσταλλικές μορφές, περιλαμβανομένων αλάτων και πολύμορφων, μιας ένωσης η οποία είναι χρήσιμη για την θεραπεία καταστάσεων που αποκρίνονται στην ένωση τετρακυκλίνης. Οι κρυσταλλικές ενώσεις είναι χρήσιμες για την θεραπεία ή πρόληψη καταστάσεων και διαταραχών τέτοιων όπως βακτηριακών λοιμώξεων και νεοπλασιών, καθώς επίσης και για άλλες γνωστές εφαρμογές των ενώσεων τετρακυκλίνης γενικά.
CY20151100497T 2008-05-23 2015-06-04 Αλατα και πολυμορφα μιας ενωσης τετρακυκλινης CY1116436T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12871208P 2008-05-23 2008-05-23
EP09751737.9A EP2296464B1 (en) 2008-05-23 2009-05-26 Salts and polymorphs of a tetracycline compound

Publications (1)

Publication Number Publication Date
CY1116436T1 true CY1116436T1 (el) 2017-02-08

Family

ID=41340587

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20151100497T CY1116436T1 (el) 2008-05-23 2015-06-04 Αλατα και πολυμορφα μιας ενωσης τετρακυκλινης
CY20201101224T CY1123705T1 (el) 2008-05-23 2020-12-29 Αλατα και πολυμορφα μιας ενωσης τετρακυκλινης

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20201101224T CY1123705T1 (el) 2008-05-23 2020-12-29 Αλατα και πολυμορφα μιας ενωσης τετρακυκλινης

Country Status (30)

Country Link
US (4) US8383610B2 (el)
EP (3) EP2807926B1 (el)
JP (6) JP5727930B2 (el)
KR (1) KR101679362B1 (el)
CN (4) CN108324722A (el)
AR (1) AR075447A1 (el)
AU (2) AU2009248795B2 (el)
BR (1) BRPI0913026B1 (el)
CA (2) CA2724897C (el)
CO (1) CO6300898A2 (el)
CY (2) CY1116436T1 (el)
DK (2) DK2807926T3 (el)
EC (1) ECSP10010704A (el)
ES (2) ES2538364T3 (el)
HK (2) HK1154757A1 (el)
HR (2) HRP20150584T1 (el)
HU (1) HUE053038T2 (el)
IL (1) IL209414A0 (el)
LT (1) LT2807926T (el)
MA (1) MA32407B1 (el)
MX (1) MX2010012622A (el)
MY (1) MY156254A (el)
NZ (2) NZ598154A (el)
PL (2) PL2807926T3 (el)
PT (2) PT2296464E (el)
RU (1) RU2500665C2 (el)
SI (2) SI2296464T1 (el)
TW (5) TW202216656A (el)
WO (1) WO2009143509A1 (el)
ZA (1) ZA201008390B (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008134048A2 (en) * 2007-04-27 2008-11-06 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds
MX2010009693A (es) 2008-03-05 2010-12-20 Paratek Pharm Innc Compuestos de monociclina y metodos de uso de la misma.
TW202216656A (zh) * 2008-05-23 2022-05-01 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
JP6574572B2 (ja) * 2011-05-12 2019-09-11 パラテック ファーマシューティカルズ インコーポレイテッド （４ｓ，４ａｓ，５ａｒ，１２ａｓ）−４−ジメチルアミノ−３，１０，１２，１２ａ−テトラヒドロキシ−７−［（メトキシ（メチル）アミノ）−メチル］−１，１１−ジオキソ−１，４，４ａ，５，５ａ，６，１１，１２ａ−オクタヒドロ−ナフタセン−２−カルボン酸アミドの結晶塩及びそれを使用する方法
PT108223B (pt) 2015-02-13 2018-05-08 Hovione Farm S A Novas formas polimórficas de minociclina base e processos para a sua preparação
TW201705962A (zh) 2015-03-23 2017-02-16 生物製藥Ｘ公司 皮膚用四環素醫藥組成物
EP3432891A4 (en) * 2016-03-24 2019-10-30 Paratek Pharmaceuticals, Inc. METHOD FOR THE TREATMENT AND PREVENTION OF C. DIFFICILE
WO2017192516A1 (en) * 2016-05-02 2017-11-09 Paratek Pharmaceuticals, Inc. 9-aminomethyl minocycline compounds and methods of use thereof in urinary tract infection (uti) treatment
JP6883593B2 (ja) * 2016-06-22 2021-06-09 山東亨利醫藥科技有限責任公司 ９−アミノメチル基置換のテトラサイクリン系化合物の結晶型及びその製造方法
TW202206081A (zh) * 2016-08-03 2022-02-16 美商派瑞泰Ｓｐｖ２有限公司 ９—胺甲基米諾四環素化合物及其用途
CA3039027A1 (en) * 2016-10-03 2018-04-12 Brivention Pharmaceutical (Shanghai) Inc. Composition comprising combination of trh analog with arundic acid, and pharmaceutically acceptable salt of arundic acid
RU2019113715A (ru) 2016-11-01 2020-12-03 Паратек Фармасьютикалс, Инк. 9-аминометилминоциклиновые соединения и их применение для лечениия внебольничной бактериальной пневмонии(вбп)
RU2632708C1 (ru) * 2016-11-14 2017-10-09 Лонг Шенг Фарма Лимитед Способ получения комбинированного антибактериального препарата
CN111484424B (zh) * 2020-04-14 2022-10-25 成都百特万合医药科技有限公司 一种合成奥马环素的方法
JP2023530415A (ja) * 2020-06-11 2023-07-18 パラテック ファーマシューティカルズ，インコーポレイテッド オマダサイクリンの結晶形態、その合成方法及びその使用方法
PT117254A (pt) 2021-05-26 2022-12-30 Hovione Farm S A Método de síntese de compostos 9-aminometil tetraciclinas
CN113433249B (zh) * 2021-07-21 2023-03-24 河北圣雪大成制药有限责任公司 一种高效液相色谱法检测米诺环素中间体有关物质的方法
CN113929593A (zh) * 2021-09-02 2022-01-14 河北圣雪大成唐山制药有限责任公司 一种土霉素-2,5-二羟基苯甲酸共晶及其制备方法
WO2023047323A1 (en) * 2021-09-24 2023-03-30 Glenmark Life Sciences Limited Process for the preparation of omadacycline tosylate

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990331A (en) 1956-11-23 1961-06-27 Pfizer & Co C Stable solutions of salts of tetracyclines for parenteral administration
US2980584A (en) 1957-10-29 1961-04-18 Pfizer & Co C Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation
US3062717A (en) 1958-12-11 1962-11-06 Pfizer & Co C Intramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation
US3019260A (en) * 1959-05-13 1962-01-30 American Cyanamid Co Process for the catalytic reduction of 6-hydroxy hydronaphthacenes
FR1430859A (el) * 1960-05-23 1966-05-25
US3165531A (en) * 1962-03-08 1965-01-12 Pfizer & Co C 13-substituted-6-deoxytetracyclines and process utilizing the same
DK122658B (da) * 1963-06-17 1972-03-27 Novo Terapeutisk Labor As Fremgangsmåde til udfældning af tetracyclinbase i krystallinsk form.
US3454697A (en) 1965-06-08 1969-07-08 American Cyanamid Co Tetracycline antibiotic compositions for oral use
US3304227A (en) 1965-07-15 1967-02-14 Loyal E Loveless Antibiotic-containing animal feed
NL6607516A (el) 1966-05-31 1967-12-01
DE1767891C3 (de) 1968-06-28 1980-10-30 Pfizer Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
CA999855A (en) * 1972-09-18 1976-11-16 Societa' Farmaceutici Italia S.P.A. Process for the preparation of tetracyclines derivatives in the 7 position
US3957980A (en) 1972-10-26 1976-05-18 Pfizer Inc. Doxycycline parenteral compositions
DE2442829A1 (de) * 1974-09-06 1976-03-18 Merck Patent Gmbh Tetracyclische verbindungen und verfahren zu ihrer herstellung
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
US4126680A (en) 1977-04-27 1978-11-21 Pfizer Inc. Tetracycline antibiotic compositions
USRE34656E (en) 1983-12-29 1994-07-05 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of bone deficiency
US4935412A (en) 1983-12-29 1990-06-19 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
US4704383A (en) 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
US4666897A (en) 1983-12-29 1987-05-19 Research Foundation Of State University Inhibition of mammalian collagenolytic enzymes by tetracyclines
US4925833A (en) 1983-12-29 1990-05-15 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
JP3016587B2 (ja) 1989-12-04 2000-03-06 ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク 非ステロイド抗炎症剤及びテトラサイクリンの配合
US5308839A (en) 1989-12-04 1994-05-03 The Research Foundation Of State University Of New York Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline
DE4031168A1 (de) 1990-10-03 1992-04-16 Degussa Keramischer werkstoff zum verblenden von metallischem zahnersatz
US5770588A (en) * 1991-02-11 1998-06-23 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions of the prevention and treatment of root caries
US5231017A (en) 1991-05-17 1993-07-27 Solvay Enzymes, Inc. Process for producing ethanol
SG52361A1 (en) 1991-10-04 1998-09-28 American Cyanamid Co Novel 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
US5494903A (en) * 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
US5258371A (en) 1992-05-29 1993-11-02 Kuraray Co., Ltd. Method to reduce connective tissue destruction
US6043225A (en) 1992-06-12 2000-03-28 Board Of Regents Of The University Of Washington Diagnosis and treatment of arterial chlamydial granuloma
EP0599397B1 (en) 1992-11-17 1996-08-28 The Research Foundation Of State University Of New York Tetracyclines including non-antimicrobial chemically-modified tetracyclines inhibit excessive collagen crosslinking during diabetes
US5523297A (en) 1993-03-02 1996-06-04 The Research Foundation Of State University Of New York Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
US6043231A (en) 1993-03-02 2000-03-28 The Research Foundation Of State Univ. Of New York Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
US5668122A (en) 1993-07-28 1997-09-16 Fife; Rose S. Method to treat cancer with tetracyclines
WO1995022529A1 (en) 1994-02-17 1995-08-24 Pfizer Inc. 9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics
US5843925A (en) * 1994-12-13 1998-12-01 American Cyanamid Company Methods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth
US5834449A (en) 1996-06-13 1998-11-10 The Research Foundation Of State University Of New York Treatment of aortic and vascular aneurysms with tetracycline compounds
US5827840A (en) * 1996-08-01 1998-10-27 The Research Foundation Of State University Of New York Promotion of wound healing by chemically-modified tetracyclines
US5789395A (en) 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US5919774A (en) 1996-12-10 1999-07-06 Eli Lilly And Company Pyrroles as sPLA2 inhibitors
US5837696A (en) 1997-01-15 1998-11-17 The Research Foundation Of State University Of New York Method of inhibiting cancer growth
US5773430A (en) * 1997-03-13 1998-06-30 Research Foundation Of State University Of New York Serine proteinase inhibitory activity by hydrophobic tetracycline
US6277067B1 (en) 1997-04-04 2001-08-21 Kerry L. Blair Method and portable colposcope useful in cervical cancer detection
US5929055A (en) 1997-06-23 1999-07-27 The Research Foundation Of State University Of New York Therapeutic method for management of diabetes mellitus
US6277061B1 (en) 1998-03-31 2001-08-21 The Research Foundation Of State University Of New York Method of inhibiting membrane-type matrix metalloproteinase
US6015804A (en) 1998-09-11 2000-01-18 The Research Foundation Of State University Of New York Method of using tetracycline compounds to enhance interleukin-10 production
US5977091A (en) 1998-09-21 1999-11-02 The Research Foundation Of State University Of New York Method of preventing acute lung injury
US5998390A (en) 1998-09-28 1999-12-07 The Research Foundation Of State University Of New York Combination of bisphosphonate and tetracycline
EP1137410B1 (en) 1998-11-18 2006-08-16 Collagenex Pharmaceuticals, Inc. Novel 4-dedimethyl aminotetracycline derivatives
DE19938198A1 (de) * 1999-08-12 2001-03-01 Deutsche Telekom Ag Verfahren zum Etablieren eines gemeinsamen Schlüssels für eine Gruppe von mindestens drei Teilnehmern
US6231894B1 (en) * 1999-10-21 2001-05-15 Duke University Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase
US7231517B1 (en) * 2000-03-03 2007-06-12 Novell, Inc. Apparatus and method for automatically authenticating a network client
ATE336481T1 (de) * 2000-07-07 2006-09-15 Tufts College 9-substituierte minocyclinverbindungen
MXPA03000056A (es) * 2000-07-07 2003-07-14 Tufts College Compuestos de tetraciclina sustituidos en posicion 7.
CZ20032780A3 (cs) 2001-03-13 2004-01-14 Paratek Pharmaceuticals, Inc. 7,9- Substituované tetracyklinové sloučeniny
US7553828B2 (en) * 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
WO2003004009A1 (en) * 2001-07-02 2003-01-16 Geneva Pharmaceuticals, Inc. Pharmaceutical composition
CN102531948A (zh) * 2002-03-08 2012-07-04 帕拉特克药品公司 氨基-甲基取代的四环素类化合物
JP4099039B2 (ja) * 2002-11-15 2008-06-11 松下電器産業株式会社 プログラム更新方法
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
JP4712325B2 (ja) * 2003-09-12 2011-06-29 株式会社リコー 通信装置、通信システム、通信方法及びプログラム
US8015399B2 (en) * 2003-09-30 2011-09-06 Ricoh Company, Ltd. Communication apparatus, communication system, certificate transmission method and program
JP4621200B2 (ja) * 2004-04-15 2011-01-26 パナソニック株式会社 通信装置、通信システム及び認証方法
AR057649A1 (es) * 2005-05-27 2007-12-12 Wyeth Corp Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas
CA2639406A1 (en) * 2006-01-24 2007-08-02 Paratek Pharmaceuticals, Inc. Methods of increasing oral bioavailability of tetracyclines
CA2649075A1 (en) * 2006-04-24 2007-11-08 Teva Pharmaceutical Industries Ltd. Tigeycline crystalline forms and processes for preparation thereof
CN101134733A (zh) * 2007-09-24 2008-03-05 合肥信风科技开发有限公司 一种替加环素的物质形态及其制备方法
MX2010009693A (es) * 2008-03-05 2010-12-20 Paratek Pharm Innc Compuestos de monociclina y metodos de uso de la misma.
PT2271348T (pt) * 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
TW202216656A (zh) * 2008-05-23 2022-05-01 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體

Also Published As

Publication number Publication date
US8383610B2 (en) 2013-02-26
IL209414A0 (en) 2011-01-31
AU2016262682A1 (en) 2016-12-15
AU2009248795A1 (en) 2009-11-26
CA2987354A1 (en) 2009-11-26
CN105348138A (zh) 2016-02-24
TW202021946A (zh) 2020-06-16
JP2015166350A (ja) 2015-09-24
CN102105058A (zh) 2011-06-22
DK2296464T3 (en) 2015-06-15
DK2807926T3 (da) 2021-01-11
CY1123705T1 (el) 2022-03-24
LT2807926T (lt) 2021-02-10
ES2538364T3 (es) 2015-06-19
US20140005420A1 (en) 2014-01-02
PT2807926T (pt) 2021-01-12
CA2724897C (en) 2017-12-19
RU2500665C2 (ru) 2013-12-10
AU2016262682B2 (en) 2018-06-28
AR075447A1 (es) 2011-04-06
KR20110022619A (ko) 2011-03-07
AU2009248795B2 (en) 2016-08-25
JP6129235B2 (ja) 2017-05-17
HUE053038T2 (hu) 2021-06-28
US20160324879A1 (en) 2016-11-10
JP2011520988A (ja) 2011-07-21
EP2296464A1 (en) 2011-03-23
MX2010012622A (es) 2010-12-21
TW201000433A (en) 2010-01-01
ZA201008390B (en) 2014-03-26
US20180104262A1 (en) 2018-04-19
CA2724897A1 (en) 2009-11-26
KR101679362B1 (ko) 2016-11-25
TWI585071B (zh) 2017-06-01
TW201741281A (zh) 2017-12-01
JP2019052184A (ja) 2019-04-04
SI2296464T1 (sl) 2015-07-31
EP2296464A4 (en) 2011-05-18
JP2017149750A (ja) 2017-08-31
MY156254A (en) 2016-01-29
CN102105058B (zh) 2015-11-25
HRP20202081T1 (hr) 2021-02-19
TW202332671A (zh) 2023-08-16
BRPI0913026A2 (pt) 2019-08-27
US20100113399A1 (en) 2010-05-06
RU2010152758A (ru) 2012-06-27
BRPI0913026B1 (pt) 2022-03-03
JP2022189916A (ja) 2022-12-22
TW202216656A (zh) 2022-05-01
TWI680117B (zh) 2019-12-21
US9227921B2 (en) 2016-01-05
JP5727930B2 (ja) 2015-06-03
HRP20150584T1 (hr) 2015-07-03
HK1204526A1 (en) 2015-11-27
CO6300898A2 (es) 2011-07-21
SI2807926T1 (sl) 2021-03-31
EP2296464B1 (en) 2015-03-04
MA32407B1 (fr) 2011-06-01
EP3827817A1 (en) 2021-06-02
CN104844472B (zh) 2018-02-13
ECSP10010704A (es) 2011-01-31
PT2296464E (pt) 2015-07-13
CN104844472A (zh) 2015-08-19
EP2807926A1 (en) 2014-12-03
EP2807926B1 (en) 2020-10-07
ES2842204T3 (es) 2021-07-13
NZ589574A (en) 2012-04-27
WO2009143509A1 (en) 2009-11-26
PL2807926T3 (pl) 2021-05-31
HK1154757A1 (en) 2012-05-04
JP2021011498A (ja) 2021-02-04
NZ598154A (en) 2013-05-31
CN108324722A (zh) 2018-07-27
PL2296464T3 (pl) 2015-08-31

Similar Documents

Publication Publication Date Title
CY1123705T1 (el) Αλατα και πολυμορφα μιας ενωσης τετρακυκλινης
CY1119175T1 (el) Καινοτομες τρικυκλικες ενωσεις
CY1121948T1 (el) Πυρρολο [1,2,f][1,2,4]tpiazineς χρησιμες για θεραπεια λοιμωξεων αναπνευστικου συγκυτιακου ιου
CY1123466T1 (el) Ν-πιπεριδινυλ ακεταμιδιου παραγωγα ως αναστολεις διαυλου ασβεστιου
CY1118650T1 (el) Παραγωγα βενζιμιδαζολιου
CY1119534T1 (el) Παραγωγα φωσφορου ως αναστολεις κινασης
CY1121364T1 (el) Νεοι κυτταροστατικοι νουκλεοζιτες 7-δεαζαπουρινης
CY1121549T1 (el) Ενωσεις 1-αρυλκαρβονυλ-4-oξυ-πιπεριδινης χρησιμες για την αγωγη νευροεκφυλιστικων παθησεων
CY1117165T1 (el) Καινοφανεις τρικυκλικες ενωσεις
CY1120269T1 (el) Ετεροδικυκλικες ενωσεις ως αναστολεις βητα-λακταμασης
CY1119049T1 (el) Υποκατεστημενα πυρρολιδινο-2-καρβοξαμιδια
CR20110195A (es) Compuestos heteroaromáticos espirocíclicos fusionados para el tratamiento de infecciones bacterianas
CY1116383T1 (el) Αντιβακτηριακες ενωσεις
CY1113485T1 (el) Ενωσεις γεφυρωμενης-πιπεριδινης τυπου υποκατεστημενης-κινοξαλινης και οι χρησεις εξ' αυτων
CO6480927A2 (es) Derivados de imidazolin-2-ona 1,3-disustituida como inhibidores de cyp17.
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
ECSP088210A (es) Bencimidazoles sustituidos y métodos de preparación
EA201100503A1 (ru) Глюкозидные производные и их применения
ECSP099818A (es) Procesos para la preparacion de pirazoles
EA201000395A1 (ru) Фунгицидные производные 2-алкилтио-2-хинолинилоксиацетамида
CY1116399T1 (el) Πυραζολυλαμινοπυριδινες ως αναστολεις της fak
ATE554066T1 (de) Entzündungshemmende substituierte cyclobutendionverbindungen
CY1116984T1 (el) ΠΑΡΑΓΩΓΑ [1,2,3]ΤΡΙΑΖΟΛΟ[4,5-d]ΠΥΡΙΜΙΔΙΝΗΣ ΩΣ ΑΓΩΝΙΣΤΕΣ ΥΠΟΔΟΧΕΑ ΚΑΝΝΑΒΙΝΟΕΙΔΩΝ 2
CY1113486T1 (el) Συντηγμενες δικυκλικες πυριμιδινες
PA8855001A1 (es) Monocarbamas